Search Results - Swaisland, A.J

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    1230 Cediranib (an oral, highly potent VEGF signalling inhibitor) in combination with saracatinib (AZD0530; a potent, selective Src inhibitor): a phase I open-label study in patients with advanced solid tumours

    1230 Cediranib (an oral, highly potent VEGF signalling inhibitor) in combination with saracatinib (AZD0530; a potent, selective Src inhibitor): a phase I open-label study in patien... by Trarbach, T, Drevs, J, Strumberg, D, Gauler, T.C, Schneider, V, Eberhardt, W.E, Collins, B, Marotti, M, Swaisland, A.J

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Polycyclic hydrocarbon epoxides: The involvement of 8,9-dihydro-8,9-dihydroxybenz (a) anthracene 10,11-oxide in reactions with the DNA of benz (a) anthracene-treated hamster embryo cells

    Polycyclic hydrocarbon epoxides: The involvement of 8,9-dihydro-8,9-dihydroxybenz (a) anthracene 10,11-oxide in reactions with the DNA of benz (a) anthracene-treated hamster embryo... by Swaisland, A.J., Hewer, A., Pal, K., Keysell, G.R., Booth, J., Grover, P.L., Sims, P.

    Published in FEBS letters
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: